![]() | يوجد فقط 14 صفحة متاحة للعرض العام |
المستخلص More than 170 million patients worldwide are chronically infected with HCV. CMV infection enhances HCV pathogenesis. The study was conducted to determine the response rate to treatment with pegylated interferon alpha and ribavirin in chronic HCV patients co-infected with CMV. Fifty cases were included (19 females &13 males) referred to outpatient clinic of the national hepatology and tropical medicine research institute (NHTMRI). The study found that CMV- HCV co-infection is predominant in Egypt, and that CMV co-infection may influence HCV treatment outcome |